A+ A-


Captagon: deconstructing the myth 



Drugs, International Challenges n° 10, OFDT, 7 p.
July 2017

Captagon, in the overwhelming majority of cases, aside from the classic "fakes", is now simply another "street name" for amphetamine or speed. This relatively commonplace substance was, until the 2000s, manufactured by Balkan, Bulgarian and Turkish networks, specialising in the synthesis of amphetamine and its transformation into tablets. Owing to law enforcement actions, part of production appears to have relocated closer to consumer markets in the Persian Gulf, and to Lebanon in particular, as shown by combined seizures of precursors, amphetamine and captagon tablets. This must be understood in the context of armed violence in the Middle East, with the outbreak of the Syrian Civil War and the break-up of Iraq, notably due to the activities of the jihadi armies. These combined events have helped sustain a series of rumours and allegations. The one often rehearsed in the media, that "commonplace" captagon is the "jihadi drug", the substance preferred by Daesh terrorists, especially in France, has been refuted by objective findings, and will remain mere speculation until proven otherwise.

Author: Laurent Laniel

Download the PDF file (1,1 Mo)











Drugs in Europe

2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.